Vir Biotechnology and GlaxoSmithKline Expand Their COVID Partnership to FluThe Motley Fool • 03/05/21
Are Options Traders Betting on a Big Move in Vir Biotechnology (VIR) Stock?Zacks Investment Research • 03/04/21
Vir Biotechnology Shares Are Trading Lower As COVID-19 Study VIR-7831 Arm To Stop EnrollmentBenzinga • 03/03/21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial ResultsGlobeNewsWire • 02/25/21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory VirusesGlobeNewsWire • 02/17/21
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021GlobeNewsWire • 02/11/21
Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions of the SARS-CoV-2 Spike Protein in the Development of TherapeuticsGlobeNewsWire • 02/01/21
Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19PRNewsWire • 01/27/21
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B VirusBusiness Wire • 01/12/21